About the offering
UgenticAI is a Regulation Crowdfunding offering raising up to $5,000,000 at $0.10 per share (Class B Common Stock), with a minimum investment of $999.96 and a campaign minimum of $10,000.04. The company is headquartered in Rockville, Maryland, and is led by founder and CEO Anik Singal, who claims 25 years of entrepreneurship and $150M+ in digital sales, along with a core leadership team including a CFO, VP of Corporate Affairs, VP of Marketing, Chief of Staff, and a Capitalize Chairman. UgenticAI's core product is a proprietary '4-Layer BIVV' (Brain, Image, Voice, Video) AI cloning platform designed to allow entrepreneurs, coaches, course creators, and thought leaders to replicate themselves digitally. The Brain Clone is trained on the user's expertise to think and respond like them; the Image Clone generates professional branded visuals on demand; the Voice Clone replicates their authentic voice for audio content; and the Video Clone places them on camera without filming. The stated mission is to help 100,000 entrepreneurs clone themselves and achieve 1 trillion collective views. The company reports three revenue lines: (1) a Cloning Service, where clients travel to the Rockville studio to have their full AI clone built; (2) a Clone Accelerator, a virtual training program; and (3) software subscriptions. UgenticAI claims it achieved more revenue in January 2026 than all of the prior year combined, generated 76,000 leads in 60 days via a cold-market challenge, holds 3,000+ video testimonials, and operates with a negative customer acquisition cost of -$26 per lead (meaning it claims to profit on each lead generated). Reported ARR is $500,000 and growing. The company also references 100M+ monthly impressions from Anik Singal's own AI clone. UgenticAI describes a broader vision of building 10 autonomous AI 'departments' covering social media, marketing compliance, podcasting, local marketing, data retargeting, paid ads, affiliate marketing, PR and media, SEO, and cold outreach — positioning itself as a full AI marketing workforce for small businesses. It claims 7 of 10 verticals are already built or in progress. The company frames itself as operating at the intersection of three converging markets: digital cloning ($3B growing to $24B by 2031), marketing automation ($6B growing to $15B by 2030), and the creator economy ($204B growing at 22% annually). Investor perks are tiered from $1,000 (10% bonus shares, UgenticAI Academy lifetime access) up to $200,000 (115% bonus shares, a private day with Anik Singal, and a full BIVV clone buildout). Intermediate tiers offer access to UgenticIQ (the Brain Clone SaaS platform), Ugentic ImageLab, Ugentic VideoLab, AI Masters Club membership, HQ intensives in Rockville, 1-on-1 consultant hours, and dedicated concierge support. A 5% additional bonus share incentive is offered to attendees of investor webinars who invest within 5 days. Use of proceeds at the maximum raise of $5M allocates 38% to acquisitions, 25% to payroll, 10% each to operations, product development, and marketing, and 7% to intermediary fees. The offering is facilitated through Jumpstart Micro, Inc. d/b/a Issuance Express, a FINRA-registered funding portal. Standard Regulation Crowdfunding risk disclosures apply, including illiquidity and potential total loss of investment.
FAQ
How much has Ugentic raised?
Ugentic has raised $349,331 of a $4.3M goal.
Where is Ugentic's campaign live?
The offering is live on Jumpstart Micro, an SEC-registered Reg CF intermediary.
What are the terms of Ugentic's raise?
Common Stock, $60.9M cap, $0.10/share.
When does Ugentic's offering close?
The stated close date is Apr 30, 2027.
